What Is-Research Funding-Pittsburgh-Researching Type 1 Diabetes
Show that you are with us here http://not1d.jdrftype1.com
Once a rough and gritty center for the steelmaking industry, Pittsburgh is now home to one lone blast furnace and a wide assortment of other industries. Pittsburgh has a tremendous base of headquarters operations for U.S. and some foreign companies in a variety of industries from banking to food processing to steel and heavy manufactured goods to pharmaceuticals. These include Alcoa, HJ Heinz, PNC Bank, PPG Industries, Mellon Bank, US Steel, Allegheny Technologies, Wesco, Bayer North America, GlaxoSmithKline, American Eagle Outfitters, General Nutrition Centers, and more. Some popular landmarks are Kellys Korner, Station Square, Cathedral of Learning, Shale’s Rinkside, Senator John Heinz History Center, Schenley Park, Prince Gallitzin State Park, Zippy’s Saloon, JD’s Cocktail Lounge, O’Reilly Theater, Mr. Rogers’ Memorial Statue, ToonSeum, East Liberty Presbyterian Church, Wigle Whiskey, The ScareHouse, The Smiling Moose, The Beer Market, The Nationality Rooms, Manor Theatre, Heinz Hall, Frick Art and Historical Center, Linden Grove, Hop Farm Brewing Company, The Society for Contemporary Craft, Murphy’s Taproom, Pittsburgh Center of the Arts, Stamoolis Brothers, Calvary United Methodist Church, James Gallery, Sandcastle Water Park, Carnegie Institute, Gator’s Saloon. In type 1 diabetes, the pancreas, a large gland behind the stomach, stops making insulin because the cells that make the insulin have been destroyed by the body’s immune system. Without insulin, the body’s cells cannot turn glucose (sugar), into energy.
People with type 1 diabetes depend on insulin every day of their lives to replace the insulin the body cannot produce. They must test their blood glucose levels several times throughout the day.
The onset of type 1 diabetes typically occurs in people under 30 years, but can occur at any age. About 10-15% of all cases of diabetes are type 1.
Without insulin the body burns its own fats as a substitute which releases chemical substances in the blood. Without ongoing injections of insulin, the dangerous chemical substances will accumulate and can be life threatening if it is not treated. This is a condition call ketoacidosis. Video Credits can be found here http://broadcaster.beazil.net/public/credits/youtube/videos/42850 JDRF prioritizes its funding for type 1 diabetes research in four interrelated therapeutic areas: autoimmune therapies, β-cell therapies, prevention of complications, and glucose control. Each therapeutic area encompasses a diverse portfolio of research programs that span from exploratory to preclinical proof-of-principle and on to clinical proof-of-concept research. The organization’s overarching strategy focuses on addressing critical gaps and challenges, catalyzing innovative and transformational research, advancing and translating research, creating collaborations, and accelerating time lines at all stages of research development. To facilitate downstream partnering and follow-on funding, JDRF increasingly supports product development by “de-risking” projects, thereby decreasing the barriers of entry for future funders. Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
Go to our blog http://jdrf.org/blog/
Check our Google Plus account https://plus.google.com/110620633690555176280/
Appreciate our videos at https://www.youtube.com/user/jdrfonline
Visit our Facebook account https://www.facebook.com/myJDRF
Subscribe to our Twitter account https://twitter.com/JDRFTypeOne
Join us at our Linkedin account https://www.linkedin.com/company/jdrf
Get familiar with our Instagram account.